000 01267 a2200373 4500
005 20250513150849.0
264 0 _c19980831
008 199808s 0 0 eng d
022 _a0190-9622
024 7 _a10.1016/s0190-9622(98)70077-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCunningham, B B
245 0 0 _aTopical calcipotriene for morphea/linear scleroderma.
_h[electronic resource]
260 _bJournal of the American Academy of Dermatology
_cAug 1998
300 _a211-5 p.
_bdigital
500 _aPublication Type: Case Reports; Clinical Trial; Journal Article
650 0 4 _aAdministration, Topical
650 0 4 _aAdolescent
650 0 4 _aCalcitriol
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aDermatologic Agents
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOintments
650 0 4 _aScleroderma, Localized
_xdrug therapy
650 0 4 _aTime Factors
700 1 _aLandells, I D
700 1 _aLangman, C
700 1 _aSailer, D E
700 1 _aPaller, A S
773 0 _tJournal of the American Academy of Dermatology
_gvol. 39
_gno. 2 Pt 1
_gp. 211-5
856 4 0 _uhttps://doi.org/10.1016/s0190-9622(98)70077-5
_zAvailable from publisher's website
999 _c9670434
_d9670434